Allergan announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In